NCT00676819View on ClinicalTrials.gov

Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

January 10, 2002

Primary Completion Date

July 19, 2002

Study Completion Date

July 19, 2002

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin aspart

DRUG

human insulin

Trial Locations (1)

50825

Novo Nordisk Investigational Site, Cologne

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT00676819 - Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes | Biotech Hunter | Biotech Hunter